13 research outputs found

    The Sudbury Neutrino Observatory

    Full text link
    The Sudbury Neutrino Observatory is a second generation water Cherenkov detector designed to determine whether the currently observed solar neutrino deficit is a result of neutrino oscillations. The detector is unique in its use of D2O as a detection medium, permitting it to make a solar model-independent test of the neutrino oscillation hypothesis by comparison of the charged- and neutral-current interaction rates. In this paper the physical properties, construction, and preliminary operation of the Sudbury Neutrino Observatory are described. Data and predicted operating parameters are provided whenever possible.Comment: 58 pages, 12 figures, submitted to Nucl. Inst. Meth. Uses elsart and epsf style files. For additional information about SNO see http://www.sno.phy.queensu.ca . This version has some new reference

    Susceptibilidad de las bacterias aisladas de infecciones gastrointestinales agudas a la rifaximina y otros agentes antimicrobianos en MĂ©xico

    No full text
    Antecedentes: La resistencia bacteriana puede dificultar el tratamiento antimicrobiano de las gastroenteritis agudas. La susceptibilidad bacteriana de los enteropatĂłgenos a la rifaximina, un antibiĂłtico que alcanza altas concentraciones fecales (hasta 8,000 Όg/g) no se ha evaluado en MĂ©xico. Objetivos: Determinar la susceptibilidad a rifaximina y a otros antimicrobianos de bacterias enteropatĂłgenas aisladas de pacientes con gastroenteritis aguda en MĂ©xico. Material y mĂ©todos: Se analizaron las cepas bacterianas en las heces de 1,000 pacientes con diagnĂłstico de gastroenteritis aguda. Se probĂł la susceptibilidad a la rifaximina (RIF) con microdiluciĂłn (< 100, < 200, < 400 y < 800 Όg/ml), la susceptibilidad a cloranfenicol (CLO), trimetoprim-sulfametoxazol (T-S), neomicina (NEO), furazolidona (FUR), fosfomicina (FOS), ampicilina (AMP) y ciprofloxacino (CIP) se probĂł por difusiĂłn-agar a las concentraciones recomendadas por CLSI y ASM. Resultados: Las bacterias aisladas fueron: Escherichia coli (E. coli) enteropatĂłgena (EPEC) 531, Shigella 120, Salmonella no-typhi 117, Aeromonas spp. 80, E. coli enterotoxigĂ©nica 54, Yersinia enterocolitica 20, Campylobacter jejuni 20, Vibrio spp. 20, Pleisiomonas shigelloides 20 y E. coli enterohemorrĂĄgica (EHEC 0:157) 18. La susceptibilidad global acumulada a RIF < 100, < 200, < 400, < 800 Όg/ml fue del 70.6, el 90.8, el 99.3 y el 100%, respectivamente. La susceptibilidad global a cada antibiĂłtico fue: AMP 32.2%, T-S 53.6%, NEO 54.1%, FUR 64.7%, CIP 67.3%, CLO 73%, FOS 81.3%. La susceptibilidad a RIF < 400 y < 800 Όg/ml fue significativamente mayor que con los otros antimicrobianos (p < 0.001). Conclusiones: La resistencia de las bacterias enteropatĂłgenas a antimicrobianos utilizados en gastroenteritis es alta. La rifaximina fue activa contra el 99-100% de las bacterias en concentraciones alcanzables en el contenido intestinal con las dosis recomendadas

    Immunocompromised patients with acute respiratory distress syndrome : Secondary analysis of the LUNG SAFE database

    Get PDF
    The aim of this study was to describe data on epidemiology, ventilatory management, and outcome of acute respiratory distress syndrome (ARDS) in immunocompromised patients. Methods: We performed a post hoc analysis on the cohort of immunocompromised patients enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study. The LUNG SAFE study was an international, prospective study including hypoxemic patients in 459 ICUs from 50 countries across 5 continents. Results: Of 2813 patients with ARDS, 584 (20.8%) were immunocompromised, 38.9% of whom had an unspecified cause. Pneumonia, nonpulmonary sepsis, and noncardiogenic shock were their most common risk factors for ARDS. Hospital mortality was higher in immunocompromised than in immunocompetent patients (52.4% vs 36.2%; p < 0.0001), despite similar severity of ARDS. Decisions regarding limiting life-sustaining measures were significantly more frequent in immunocompromised patients (27.1% vs 18.6%; p < 0.0001). Use of noninvasive ventilation (NIV) as first-line treatment was higher in immunocompromised patients (20.9% vs 15.9%; p = 0.0048), and immunodeficiency remained independently associated with the use of NIV after adjustment for confounders. Forty-eight percent of the patients treated with NIV were intubated, and their mortality was not different from that of the patients invasively ventilated ab initio. Conclusions: Immunosuppression is frequent in patients with ARDS, and infections are the main risk factors for ARDS in these immunocompromised patients. Their management differs from that of immunocompetent patients, particularly the greater use of NIV as first-line ventilation strategy. Compared with immunocompetent subjects, they have higher mortality regardless of ARDS severity as well as a higher frequency of limitation of life-sustaining measures. Nonetheless, nearly half of these patients survive to hospital discharge. Trial registration: ClinicalTrials.gov, NCT02010073. Registered on 12 December 2013

    Nopal (Opuntia spp.) and its Effects on Metabolic Syndrome: New Insights for the Use of a Millenary Plant

    No full text

    Neutral current and day night measurements from the pure D2O phase of SNO

    No full text
    The Sudbury Neutrino Observatory is a 1000 T D2O Cerenkov detector that is sensitive to 8B solar neutrinos. The energy, radius, and direction with respect to the sun is measured for each neutrino event; these distributions are used to separately determine the rates of the charged current, neutral current and electron scattering reactions of neutrinos on deuterium. Assuming an undistorted 8B spectrum, the Îœe component of the 8B solar flux is φe = 1.76-0.05 +0.05 (stat. -0.09 +0.09 (syst.) × 106 cm-2s-1 based on events with a measured kinetic energy above 5 MeV. The non-Îœe component is φΌτ = 3.41-0.45 +0.45 (stat. -0.45 +0.48 (syst.) × 106 cm-2s-1, 5.3σ greater than zero, providing strong evidence for solar Îœe flavor transformation. The total flux measured with the NC reaction is φNC = 5.09-0.43 +0.44(stat. -0.43 +0.46 (syst.) × 106 cm-2s-1, consistent with solar models. The night minus day rate is 14.0% ± 6.3%-1.4 +1.5% of the average rate. If the total flux of active neutrinos is additionally constrained to have no asymmetry, the Îœe asymmetry is found to be 7.0% ± 4.9%-1.2 +1.3%. A global solar neutrino analysis in terms of matter-enhanced oscillations of two active flavors strongly favors the Large Mixing Angle (LMA) solution

    First neutrino observations from the sudbury neutrino observatory

    No full text
    The first neutrino observations from the Sudbury Neutrino Observatory are presented from preliminary analyses. Based on energy, direction and location, the data in the region of interest appear to be dominated by 8B solar neutrinos, detected by the charged current reaction on deuterium and elastic scattering from electrons, with very little background. Measurements of radioactive backgrounds indicate that the measurement of all active neutrino types via the neutral current reaction on deuterium will be possible with small systematic uncertainties. Quantitative results for the fluxes observed with these reactions will be provided when further calibrations have been completed

    Measurement of CC interactions produced by8B solar neutrinos at SNO

    No full text
    The Sudbury Neutrino Observatory (SNO) is a 1000 tonne heavy water Cherenkov detector placed 2 km underground in Ontario, Canada. Its main purpose is the detection of solar neutrinos, but it is also sensitive to atmospheric and supernova neutrinos. In this paper we report our first measurement of the solar electron-type neutrino flux using the charged current interaction on deuterium, above an electron kinetic energy threshold of 6.75 MeV. This measurement, when compared with an electron scattering measurement from Super Kamiokande, provides the first evidence for non-electron neutrino types from the Sun implying flavor change of solar electron neutrinos. We also present an initial angular distribution of through-going muons, which shows that we can detect neutrino-induced muons from well above the horizontal. This will give us good sensitivity to neutrino oscillations in the atmospheric sector

    Mechanical ventilation in patients with cardiogenic pulmonary edema : a sub-analysis of the LUNG SAFE study

    No full text
    Patients with acute respiratory failure caused by cardiogenic pulmonary edema (CPE) may require mechanical ventilation that can cause further lung damage. Our aim was to determine the impact of ventilatory settings on CPE mortality. Patients from the LUNG SAFE cohort, a multicenter prospective cohort study of patients undergoing mechanical ventilation, were studied. Relationships between ventilatory parameters and outcomes (ICU discharge/hospital mortality) were assessed using latent mixture analysis and a marginal structural model. From 4499 patients, 391 meeting CPE criteria (median age 70 [interquartile range 59-78], 40% female) were included. ICU and hospital mortality were 34% and 40%, respectively. ICU survivors were younger (67 [57-77] vs 74 [64-80] years, p < 0.001) and had lower driving (12 [8-16] vs 15 [11-17] cmHO, p < 0.001), plateau (20 [15-23] vs 22 [19-26] cmHO, p < 0.001) and peak (21 [17-27] vs 26 [20-32] cmHO, p < 0.001) pressures. Latent mixture analysis of patients receiving invasive mechanical ventilation on ICU day 1 revealed a subgroup ventilated with high pressures with lower probability of being discharged alive from the ICU (hazard ratio [HR] 0.79 [95% confidence interval 0.60-1.05], p = 0.103) and increased hospital mortality (HR 1.65 [1.16-2.36], p = 0.005). In a marginal structural model, driving pressures in the first week (HR 1.12 [1.06-1.18], p < 0.001) and tidal volume after day 7 (HR 0.69 [0.52-0.93], p = 0.015) were related to survival. Higher airway pressures in invasively ventilated patients with CPE are related to mortality. These patients may be exposed to an increased risk of ventilator-induced lung injury. Trial registration Clinicaltrials.gov NCT02010073
    corecore